| Diabetic retinopathy: A comprehensive review CA Shah Indian journal of medical sciences 62 (12), 500-519, 2008 | 113 | 2008 |
| Adherence to high activity antiretrovial therapy (HAART) in pediatric patients infected with HIV: issues and interventions CA Shah The Indian Journal of Pediatrics 74 (1), 55-60, 2007 | 102 | 2007 |
| Detection and prevention of phishing websites using machine learning approach V Patil, P Thakkar, C Shah, T Bhat, SP Godse 2018 Fourth international conference on computing communication control and …, 2018 | 71 | 2018 |
| A comparative study to assess the efficacy, safety, and immunogenicity of YLB113 and the etanercept reference product for the treatment of patients with rheumatoid arthritis H Yamanaka, N Kamatani, Y Tanaka, T Hibino, E Drescher, ... Rheumatology and Therapy 7, 149-163, 2020 | 22 | 2020 |
| Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2 … N Sinha, NP Karche, MK Verma, SS Walunj, PB Nigade, G Jana, ... Journal of Medicinal Chemistry 63 (3), 944-960, 2019 | 21 | 2019 |
| E-agro android application (integrated farming management systems for sustainable development of farmers) S Sharma, V Patodkar, S Simant, C Shah, S Godse International Journal of Engineering Research and General Science 3 (1), 4-8, 2015 | 18 | 2015 |
| Comparative study of pulmonary function tests in smokers and non-smokers A Mistry, R Tyagi, J Kagathara, L Vaidya, U Dholakiya, C Shah GCSMC J Med Sci 3 (1), 22-27, 2014 | 15 | 2014 |
| A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s Ranibizumab with Lucentis® in patients … R Singh, R Chauhan, A Saxena, A Shah, L Mondal, D Bakhle, C Shah, ... Indian Journal of Ophthalmology 70 (8), 3008-3014, 2022 | 13 | 2022 |
| Pharmaceutical research in India: current status and opportunities M Sindkhedkar, S Jagtap, C Shah, VP Palle Proc Indian Natl Sci Acad 86 (2), 1015-22, 2020 | 8 | 2020 |
| Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-N-(2′-methyl-3′-(4-methyl-5-oxo-4,5-dihydro-1,3,4 … NR Khedkar, NR Irlapatti, D Dadke, V Kanoje, Z Shaikh, V Karche, ... Journal of Medicinal Chemistry 64 (23), 17004-17030, 2021 | 6 | 2021 |
| Can roflumilast become steroid-sparing alternative in the treatment of COVID-19? CA Shah Medical Hypotheses 144, 110246, 2020 | 5 | 2020 |
| Lower anti-drug antibodies with etanercept biosimilar: can Ctrough explain the differences? CA Shah Annals of the Rheumatic Diseases 75 (9), e60-e60, 2016 | 5 | 2016 |
| Lower injection‐site reactions and long‐term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post‐hoc analysis of a double‐blind … H Yamanaka, Y Tanaka, T Hibino, G Unmesh, C Shah, D Bakhle, ... International Journal of Rheumatic Diseases 26 (1), 108-115, 2023 | 3 | 2023 |
| Discovery of LNP1892: A Precision Calcimimetic for the Treatment of Secondary Hyperparathyroidism MR Shukla, G Sadasivam, A Sarde, M Sayyed, V Pachpute, R Phadtare, ... Journal of Medicinal Chemistry 66 (14), 9418-9444, 2023 | 2 | 2023 |
| Comparison of Efficacy and Safety of Lupin’s Pegfilgrastim with Neulastim® as an Adjunct to Chemotherapy in Patients with NonMyeloid Malignancies: A Randomised Phase III … M JAIN, S DESAI, R NAGARKAR, R NEVE, U TAKALKAR, D BAKHLE, ... Journal of Clinical & Diagnostic Research 16 (8), 2022 | 1 | 2022 |
| AB0416 A COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF YLB113 AND ETANERCEPT REFERENCE PRODUCT FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID … H Yamanaka, N Kamatani, Y Tanaka, T Hibino, E Drescher, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1670-1670, 2019 | 1 | 2019 |
| Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An … SH Advani, H Malhotra, RT Chacko, M Basade, P Keechilat, ... Indian Journal of Cancer 54 (Suppl 1), S31-S36, 2017 | 1 | 2017 |
| Post-pandemic planning: how should general practice change?: Medical students' perspective T Kotwal, C Shah, A Chani, K Chahal, K Thomas | | 2023 |
| Response to commentary on: A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin’s ranibizumab … C Shah, K Sonkusare Indian Journal of Ophthalmology 71 (3), 1054-1055, 2023 | | 2023 |
| Pharmaceutical Composition of CASR Modulators and Methods and Uses Thereof RK Kamboj, DS Bakhle, CA Shah US Patent App. 17/789,343, 2023 | | 2023 |
